Insights

Targeted Proteomics Small team with specialized capabilities in cell surface target and off-target identification using LC-MS/MS based LRC-TriCEPS and Flow-TriCEPS technologies, presenting a niche but high-value service offering for drug discovery and academic research collaborations.

Collaborative Potential Recent collaboration with aTyr Pharma indicates openness to research partnerships and joint development opportunities, suggesting a receptive posture for new sponsorships, co-development projects, or fee-for-service collaborations with biotech and pharma entities.

Market Positioning Focus on proteomics services for ligands, proteins, peptides, and viruses positions the company to support target identification and mechanism studies, appealing to biotech startups and academia seeking specialized proteomics workflows.

Growth Levers Revenue is currently under one million with existing funding of 310K, signaling an opportunity to pursue grant support, larger client engagements, or phased service offerings to scale revenue and expand client base.

Digital & Outreach Active tech stack and online presence (Google Ads, WordPress, LinkedIn, MailChimp) enable scalable digital marketing, lead capture, and prospect nurturing to expand client reach in biotech and academic communities.

Similar companies to Dualsystems Biotech

Dualsystems Biotech Tech Stack

Dualsystems Biotech uses 8 technology products and services including Google Ads, WordPress, Microsoft 365, and more. Explore Dualsystems Biotech's tech stack below.

Dualsystems Biotech's Email Address Formats

Dualsystems Biotech uses at least 2 email formats:
Dualsystems Biotech Email FormatsExamplePercentage
First.Last@dualsystems.comJohn.Doe@dualsystems.com
94%
Last@dualsystems.comDoe@dualsystems.com
6%

Frequently Asked Questions

What is Dualsystems Biotech's official website and social media links?

Minus sign iconPlus sign icon
Dualsystems Biotech's official website is dualsystems.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Dualsystems Biotech generate?

Minus sign iconPlus sign icon
As of October 2026, Dualsystems Biotech's annual revenue is estimated to be <$1M.

What is Dualsystems Biotech's SIC code and NAICS code?

Minus sign iconPlus sign icon
Dualsystems Biotech's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Dualsystems Biotech have currently?

Minus sign iconPlus sign icon
As of October 2026, Dualsystems Biotech has approximately 8 employees across 2 continents, including Europe and North America. Key team members include Ceo: P. H., Member Board Of Directors: J. Z. H. and Member Of The Board Of Directors: M. O. H. Explore Dualsystems Biotech's employee directory with LeadIQ.

What industry does Dualsystems Biotech belong to?

Minus sign iconPlus sign icon
Dualsystems Biotech operates in the Biotechnology Research industry.

What technology does Dualsystems Biotech use?

Minus sign iconPlus sign icon
Dualsystems Biotech's tech stack includes Google Ads, WordPress, Microsoft 365, Zendesk Chat, Priority Hints, Yoast SEO, MailChimp for WordPress and LinkedIn Profile Widget.

What is Dualsystems Biotech's email format?

Minus sign iconPlus sign icon
Dualsystems Biotech's email format typically follows the pattern of First.Last@dualsystems.com. Find more Dualsystems Biotech email formats with LeadIQ.

How much funding has Dualsystems Biotech raised to date?

Minus sign iconPlus sign icon
As of October 2026, Dualsystems Biotech has raised $310K in funding. The last funding round occurred on Sep 30, 2013.

When was Dualsystems Biotech founded?

Minus sign iconPlus sign icon
Dualsystems Biotech was founded in 2001.
Dualsystems Biotech logo

Dualsystems Biotech

Biotechnology ResearchZurich, Switzerland2-10 Employees

Dualsystems Biotech is a Swiss biotechnology service provider specializing in custom proteomics for industry and academia. The company identifies targets and off-targets on living cell membranes using ligand-receptor capture technology, enabling researchers to characterize interactions for ligands such as proteins, peptides, and viruses, with recent advances suggesting small molecule targets can also be identified. Its offerings help clients optimize binding conditions prior to major identification experiments, supporting drug discovery and therapeutic development efforts. Based in Schlieren, near Zurich, Dualsystems Biotech operates with a focus on enabling detailed target identification in proteomics research. The firm positions itself within the proteomics services market by providing contract-based analysis to identify membrane-associated interactions in living cells, addressing a need for precise target mapping in both industry and academic settings. A recent development includes a collaboration with aTyr Pharma to accelerate drug discovery and generate new therapeutics based on aTyr’s IP portfolio.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2001
Employees
2-10

Section iconFunding & Financials

  • $310K

    Dualsystems Biotech has raised a total of $310K of funding over 2 rounds. Their latest funding round was raised on Sep 30, 2013 as a Series C.

  • <$1M

    Dualsystems Biotech's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.